The impact of splenectomy on outcome after resection for colorectal cancer: A multicenter, nested, paired cohort study

Diseases of the Colon and Rectum

Volumn 51, Issue 2, 2008, Pages 213-217

  Wakeman, C J ^a   Dobbs, B R ^a   Frizelle, F A ^a   Bissett, I P ^b   Dennett, E R ^c   Hill, A G ^d   Thompson Fawcett, M W ^e  

^a CHRISTCHURCH HOSPITAL   (New Zealand)

^b AUCKLAND CITY HOSPITAL   (New Zealand)

^c WELLINGTON HOSPITAL   (New Zealand)

^d MIDDLEMORE HOSPITAL   (New Zealand)

^e DUNEDIN HOSPITAL   (New Zealand)

Author keywords

Anterior resection; Colorectal cancer; Spleen; Splenectomy; Survival

Indexed keywords

ADULT; AGED; ARTICLE; CANCER SURGERY; CANCER SURVIVAL; COHORT ANALYSIS; COLORECTAL CANCER; CONFIDENCE INTERVAL; CONTROLLED STUDY; DATA ANALYSIS; FEMALE; FOLLOW UP; HAZARD RATIO; HUMAN; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; MEDICAL SOCIETY; OUTCOME ASSESSMENT; PROPORTIONAL HAZARDS MODEL; RETROSPECTIVE STUDY; SPLENECTOMY; SURGICAL MORTALITY; SURVIVAL RATE; SURVIVAL TIME;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; COLORECTAL NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; HUMANS; IATROGENIC DISEASE; INTRAOPERATIVE COMPLICATIONS; MALE; MIDDLE AGED; NEW ZEALAND; PROGNOSIS; RETROSPECTIVE STUDIES; SPLEEN; SPLENECTOMY; SURVIVAL RATE; TIME FACTORS;

EID: 39149104022     PISSN: 00123706     EISSN: 15300358     Source Type: Journal    
DOI: 10.1007/s10350-007-9139-6     Document Type: Article

References (12)

1. Shaw JH, Print CG. Postsplenectomy sepsis. Br J Surg 1989;76:1074-81.
2. Suehiro S, Nagasue N, Ogawa Y, Sasaki Y, Hirose S, Yukaya H. The negative effect of splenectomy on the prognosis of gastric cancer. Am J Surg 1984;148:645-8.
3. Shen JG, Cheong JH, Hyung WJ, Kim J, Choi SH, Noh SH. Adverse effect of splenectomy on recurrence in total gastrectomy cancer patients with perioperative transfusion. Am J Surg 2006;192:301-5.
4. Saji S, Sakamoto J, Teramukai S, et al. Impact of splenectomy and immunochemotherapy on survival following gastrectomy for carcinoma: covariate interaction with immunosuppressive acidic protein, a serum marker for the host immune system. Tumor Marker Committee for the Study Group of Immunochemotherapy with PSK for Gastric Cancer. Surg Today 1999;29:504-10.
5. Gockel I, Kneist W, Junginger T. Influence of splenectomy on perioperative morbidity and long-term survival after esophagectomy in patients with esophageal carcinoma. Dis Esophagus 2005;18:311-5.
6. Brennan MF, Kattan MW, Klimstra D, Conlon K. Prognostic nomogram for patients undergoing resection for adenocarcinoma of the pancreas. Ann Surg 2004;240:293-8.
7. Schwarz RE, Harrison LE, Conlon KC, Klimstra DS, Brennan MF. The impact of splenectomy on outcomes after resection of pancreatic adenocarcinoma. J Am Coll Surg 1999;188:516-21.
8. Davis CJ, Ilstrup DM, Pemberton JH. Influence of splenectomy on survival rate of patients with colorectal cancer. Am J Surg 1988;155:173-9.
9. Varty PP, Linehan IP, Boulos PB. Does concurrent splenectomy at colorectal cancer resection influence survival? Dis Colon Rectum 1993;36:602-6.
10. Konstadoulakis MM, Kymionis GD, Leandros E, et al. Long-term effect of splenectomy on patients operated on for cancer of the left colon: a retrospective study. Eur J Surg 1999;165:583-7.
11. Fletcher J. Subgroup analyses: how to avoid being misled. BMJ 2007;335:96-7.
12. Cook DI, Gebski VJ, Keech AC Subgroup analysis in clinical trails. In: Keech A, Gebski V, Pike R. Interpreting and reporting clinical trials. Sydney, Australia: Medical Journal of Australia, 2007:105-13.